Swedbank AB Has $67.86 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Swedbank AB lowered its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 13.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 114,181 shares of the biotechnology company's stock after selling 18,422 shares during the period. Swedbank AB owned approximately 0.15% of Axon Enterprise worth $67,860,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of AXON. Geode Capital Management LLC increased its holdings in shares of Axon Enterprise by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company's stock valued at $710,103,000 after purchasing an additional 35,320 shares during the period. Westfield Capital Management Co. LP lifted its position in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company's stock worth $469,661,000 after buying an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC boosted its stake in shares of Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company's stock valued at $272,695,000 after buying an additional 83,265 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company's stock valued at $224,281,000 after acquiring an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment acquired a new position in shares of Axon Enterprise in the third quarter worth $200,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Northland Securities increased their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a report on Monday, November 11th. Morgan Stanley upgraded shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and raised their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. JMP Securities upped their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a "market outperform" rating in a report on Thursday, October 31st. The Goldman Sachs Group raised their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday. Finally, Needham & Company LLC upped their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a research note on Friday, November 8th. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $524.85.

Axon Enterprise Stock Performance

NASDAQ:AXON traded up $6.45 during trading hours on Thursday, hitting $646.42. 184,188 shares of the company traded hands, compared to its average volume of 546,801. The firm has a 50-day moving average of $618.90 and a 200 day moving average of $477.78. The stock has a market capitalization of $49.29 billion, a price-to-earnings ratio of 167.03, a P/E/G ratio of 6.09 and a beta of 1.04. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $247.04 and a twelve month high of $698.67.

Insider Buying and Selling

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm's stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, President Joshua Isner sold 20,000 shares of the firm's stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the transaction, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. This trade represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock valued at $30,721,337 over the last three months. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.